Apr 15, 2026, 2:17 AMdefenseworld.netMRVFF
Analyzing Nuvo Pharmaceuticals (OTCMKTS:MRVFF) and Intellipharmaceutics International (OTCMKTS:IPCIF)
Financial reports
Valuation and Earnings This table compares Nuvo Pharmaceuticals and Intellipharmaceutics International"s revenue, earnings per share (EPS) and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nuvo Pharmaceuticals $54.98 million 0.20 -$25.70 million ($0.12) -8.16 Intellipharmaceutics International $660,000.00 0.00 -$2.89 million ($0.16) N/A Intellipharmaceutics International has lower revenue, but higher earnings than
